Objective: To prospectively evaluate the survival benefit of dissection of the nerve plexus
and lymphadenectomy in patients with pancreatic head cancer. Background: Despite …

High intensity focused ultrasound (HIFU) is a novel therapeutic modality. Several preclinical
and clinical studies have investigated the safety and efficacy of HIFU for treating solid …

Background Our previous randomized controlled trial revealed no difference in 2‐year
overall survival (OS) between extended and standard resection for pancreatic …

Over 55,000 people in the United States are diagnosed with pancreatic ductal
adenocarcinoma (PDAC) yearly, and fewer than 20% of these patients survive a year …

Aims: The aim of this study was to evaluate the efficacy, safety, and survival factors of high-
intensity focused ultrasound (HIFU) ablation in the treatment of advanced pancreatic cancer …

There is currently tremendous interest in developing anti-cancer therapeutics targeting cell
signaling pathways important for both cancer cell metabolism and growth. Several …

Background Pancreatectomy with regional lymphadenectomy remains the only curative
treatment option for pancreatic cancer. There is no clear consensus on what type of adjuvant …

Pancreatic cancer has one of the lowest survival rates of all cancers. The mechanism
underlying chemo-resistance of pancreatic cancer is not well understood. Our previous …

Pulmonary artery (PA) leiomyosarcoma (PAL) is a rare but extremely malignant tumor of the
cardiovascular system, which is often misdiagnosed as pulmonary thromboembolism …

Stereotactic body radiation therapy as an effective treatment for pancreatic cancer patients
with local advanced stage Page 1 Page 1/12 Stereotactic body radiation therapy as an …